{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":55,"mapped":1},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P10415","source":"P10415|Apoptosis regulator Bcl-2","targets":["1G5M|HUMAN BCL-2, ISOFORM 1|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","1GJH|HUMAN BCL-2, ISOFORM 2|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","1YSW|Solution structure of the anti-apoptotic protein Bcl-2 complexed with an acyl-sulfonamide-based ligand|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","2O21|Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","2O22|Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","2O2F|Solution structure of the anti-apoptotic protein Bcl-2 in complex with an acyl-sulfonamide-based ligand|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","2W3L|Crystal Structure of Chimaeric Bcl2-xL and Phenyl Tetrahydroisoquinoline Amide Complex|X-RAY DIFFRACTION|2.1|HOMO SAPIENS|0|APOPTOSIS","2XA0|Crystal structure of BCL-2 in complex with a BAX BH3 peptide|X-RAY DIFFRACTION|2.7|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|APOPTOSIS","4AQ3|HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR|X-RAY DIFFRACTION|2.4|HOMO SAPIENS|0|APOPTOSIS","4IEH|Crystal Structure of human Bcl-2 in complex with a small molecule inhibitor targeting Bcl-2 BH3 domain interactions|X-RAY DIFFRACTION|2.1|Homo sapiens|0|APOPTOSIS/INHIBITOR","4LVT|Bcl_2-Navitoclax (ABT-263) Complex|X-RAY DIFFRACTION|2.05|Homo sapiens|0|APOPTOSIS REGULATOR/INHIBITOR","4LXD|Bcl_2-Navitoclax Analog (without Thiophenyl) Complex|X-RAY DIFFRACTION|1.9|Homo sapiens|0|APOPTOSIS REGULATOR/INHIBITOR","4MAN|Bcl_2-Navitoclax Analog (with Indole) Complex|X-RAY DIFFRACTION|2.07|Homo sapiens|0|APOPTOSIS REGULATOR/INHIBITOR","5AGW|Bcl-2 alpha beta-1 complex|X-RAY DIFFRACTION|2.695|HOMO SAPIENS|0|APOPTOSIS","5AGX|Bcl-2 alpha beta-1 LINEAR complex|X-RAY DIFFRACTION|2.24|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|APOPTOSIS","5FCG|Crystal structure of Bcl-2 in complex with HBx-BH3 motif|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","5JSN|Bcl2-inhibitor complex|X-RAY DIFFRACTION|2.1|Homo sapiens; unidentified|0|Viral Protein/Inhibitor","5VAU|Bcl-2 complex with Beclin 1 BH3 domain|X-RAY DIFFRACTION|1.754|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","5VAX|Bcl-2 complex with Beclin 1 BH3 domain|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","5VAY|Bcl-2 complex with Beclin 1 T108D BH3 domain|X-RAY DIFFRACTION|1.804|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","6GL8|Crystal structure of Bcl-2 in complex with the novel orally active inhibitor S55746|X-RAY DIFFRACTION|1.4|Homo sapiens|0|APOPTOSIS","6IWB|Crystal structure of a computationally designed protein (LD3) in complex with BCL-2|X-RAY DIFFRACTION|2.5|Homo sapiens|0|APOPTOSIS","6O0K|crystal structure of BCL-2 with venetoclax|X-RAY DIFFRACTION|1.62|Homo sapiens|0|APOPTOSIS","6O0L|crystal structure of BCL-2 G101V mutation with venetoclax|X-RAY DIFFRACTION|2.2|Homo sapiens|0|APOPTOSIS","6O0M|crystal structure of BCL-2 F104L mutation with venetoclax|X-RAY DIFFRACTION|1.75|Homo sapiens|0|APOPTOSIS","6O0O|crystal structure of BCL-2 G101V mutation with S55746|X-RAY DIFFRACTION|1.998|Homo sapiens|0|APOPTOSIS","6O0P|crystal structure of BCL-2 G101A mutation with venetoclax|X-RAY DIFFRACTION|1.8|Homo sapiens|0|APOPTOSIS","6QG8|Structure of human Bcl-2 in complex with PUMA BH3 peptide|X-RAY DIFFRACTION|1.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","6QGG|Structure of human Bcl-2 in complex with analogue of ABT-737|X-RAY DIFFRACTION|1.5|Homo sapiens|0|APOPTOSIS","6QGH|Structure of human Bcl-2 in complex with ABT-263|X-RAY DIFFRACTION|2|Homo sapiens|0|APOPTOSIS","6QGJ|Structure of human Bcl-2 in complex with fragment/ABT-263 hybrid|X-RAY DIFFRACTION|1.9|Homo sapiens|0|APOPTOSIS","6QGK|Structure of human Bcl-2 in complex with THIQ-phenyl pyrazole compound|X-RAY DIFFRACTION|1.8|Homo sapiens|0|APOPTOSIS","7LHB|Crystal structure of Bcl-2 in complex with prodrug ABBV-167|X-RAY DIFFRACTION|2.068|Homo sapiens; synthetic construct|0|APOPTOSIS","7Y90|Crystal Structure Analysis of cp1 bound BCL2|X-RAY DIFFRACTION|2.09|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","7YA5|Crystal structure analysis of cp1 bound BCL2/G101V|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","7YB7|anti-apoptotic protein BCL-2-M12|X-RAY DIFFRACTION|2.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","8FY1|E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2)|X-RAY DIFFRACTION|2.56|Homo sapiens|0|TRANSCRIPTION","8FY2|E3:PROTAC:target ternary complex structure (VCB/WH244/BCL-2)|X-RAY DIFFRACTION|2.98|Homo sapiens|0|TRANSCRIPTION","8HLL|Crystal structure of p53/BCL2 fusion complex (complex 1)|X-RAY DIFFRACTION|2.62|Homo sapiens|0|APOPTOSIS","8HLM|Crystal structure of p53/BCL2 fusion complex (complex 2)|X-RAY DIFFRACTION|2.522|Homo sapiens|0|APOPTOSIS","8HLN|Crystal structure of p53/BCL2 fusion complex(complex3)|X-RAY DIFFRACTION|2.354|Homo sapiens|0|APOPTOSIS","8HOG|Crystal structure of Bcl-2 in complex with sonrotoclax|X-RAY DIFFRACTION|1.8|Homo sapiens|0|APOPTOSIS","8HOH|Crystal structure of Bcl-2 G101V in complex with sonrotoclax|X-RAY DIFFRACTION|1.9|Homo sapiens|0|APOPTOSIS","8HOI|Crystal structure of Bcl-2 D103Y in complex with sonrotoclax|X-RAY DIFFRACTION|2.25|Homo sapiens|0|APOPTOSIS","8HTR|Crystal structure of Bcl2 in complex with S-9c|X-RAY DIFFRACTION|1.6|Homo sapiens|0|APOPTOSIS","8HTS|Crystal structure of Bcl2 in complex with S-10r|X-RAY DIFFRACTION|1.25|Homo sapiens|0|APOPTOSIS","8IQL|Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival proteins|X-RAY DIFFRACTION|2.9577|Homo sapiens|0|APOPTOSIS","8U27|Bcl-2-xL complexed with compound 35|SOLUTION NMR||Homo sapiens|0|APOPTOSIS","8VWX|Human Bcl-2 (G101V Mutant)/Bcl-xL Chimera Fused to Maltose-Binding Protein|X-RAY DIFFRACTION|1.77|Escherichia coli (strain K12); Homo sapiens|0|APOPTOSIS","8VWZ|Human Bcl-2 (G101V Mutant)/Bcl-xL Chimera Fused to MBP in Complex with Inhibitor S55746|X-RAY DIFFRACTION|2.33|Escherichia coli K-12; Homo sapiens|0|APOPTOSIS","8VXM|Human Bcl-2/Bcl-xL Chimera Fused to MBP in Complex with Inhibitor S55746|X-RAY DIFFRACTION|2.1|Escherichia coli K-12; Homo sapiens|0|APOPTOSIS","8VXN|Human Bcl-2/Bcl-xL Chimera Fused to Maltose-Binding Protein|X-RAY DIFFRACTION|2.09|Escherichia coli (strain K12); Homo sapiens|0|APOPTOSIS","9O14|Crystal Structure of BCL-2 in complex with a stapled BAD BH3 peptide BAD SAHB 4.2|X-RAY DIFFRACTION|1.73|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","9O15|Crystal Structure of BCL-2 (G101V) mutant in complex with a stapled BAD BH3 peptide BAD SAHB 4.2|X-RAY DIFFRACTION|1.99|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS","9O16|Crystal Structure of human BCL-2 (R129L) mutant in complex with a stapled BAD BH3 peptide BAD SAHB 4.2|X-RAY DIFFRACTION|1.73|Homo sapiens; SYNTHETIC CONSTRUCT|0|APOPTOSIS"]}]}